Autonomic Nervous System Drugs Practice Questions

Q: Lid retraction is a side effect of which anti-glaucoma drug?

Brimonidine. **Explanation:** **Brimonidine** is a highly selective **alpha-2 (α2) adrenergic agonist** used to treat glaucoma by decreasing aqueous humor production and increasing uveoscleral outflow. The side effect of **lid retraction** occurs because Brimonidine has a slight cross-reactivity with **alpha-1 (α1) receptors**. Stimulation of α1 receptors on the **superior tarsal muscle (Müller’s muscle)** causes it to contract, leading to an upward displacement of the upper eyelid (lid retraction) and a widened palpebral fissure. **Analysis of Incorrect Options:** * **Latanoprost (Prostalgandin Analog):** Known for causing **Prostalgandin-associated Periorbitopathy (PAP)**, which includes deepening of the eyelid sulcus, eyelash darkening/growth, and iris hyperpigmentation, but not lid retraction. * **Brinzolamide (Carbonic Anhydrase Inhibitor):** Primarily causes local irritation, bitter taste (dysgeusia), and transient blurred vision. It does not affect the sympathetic innervation of the eyelid. * **Pilocarpine (Cholinergic Agonist):** A miotic agent that typically causes **miosis** (pupillary constriction) and **brow ache** due to ciliary muscle contraction. It may cause mild ptosis (drooping) rather than retraction. **NEET-PG High-Yield Pearls:** * **Brimonidine** is contraindicated in infants and children (<2 years) as it can cross the blood-brain barrier and cause **CNS depression and apnea**. * It is frequently associated with **allergic conjunctivitis** (follicular conjunctivitis). * **Apraclonidine**, another alpha-agonist, is also known to cause lid retraction and is sometimes used clinically to temporarily treat ptosis in Horner’s syndrome.

Q: Which skeletal muscle relaxant is the drug of choice in patients with liver failure?

Atracurium. **Explanation:** The correct answer is **Atracurium**. **Why Atracurium is the Drug of Choice:** In patients with liver or renal failure, the metabolism of most neuromuscular blocking agents (NMBAs) is impaired, leading to prolonged paralysis. Atracurium (and its isomer Cisatracurium) is unique because it undergoes **Hofmann Elimination**. This is a spontaneous, non-enzymatic degradation that occurs at physiological pH and temperature. Additionally, it is metabolized by **nonspecific ester hydrolysis**. Since neither process depends on hepatic or renal function, the duration of action remains predictable even in end-stage liver disease. **Analysis of Incorrect Options:** * **Gallamine (A):** This is a long-acting relaxant that is excreted almost entirely unchanged by the kidneys. It is contraindicated in renal failure and rarely used today due to significant tachycardia. * **Thiopentone (B):** This is an intravenous induction agent (barbiturate), not a skeletal muscle relaxant. It is metabolized by the liver, so its half-life may actually be prolonged in liver failure. * **Lignocaine (D):** This is a local anesthetic and anti-arrhythmic agent. It is not a skeletal muscle relaxant. **High-Yield Clinical Pearls for NEET-PG:** 1. **Cisatracurium:** Often preferred over Atracurium in clinical practice because it is more potent, does not cause histamine release, and also undergoes Hofmann elimination. 2. **Laudanosine:** A metabolite of Atracurium/Cisatracurium that can cross the blood-brain barrier; in very high concentrations, it may act as a CNS stimulant (pro-convulsant). 3. **Vecuronium/Rocuronium:** These are primarily metabolized and excreted by the liver/bile; their effects are significantly prolonged in liver failure. 4. **Succinylcholine:** Its metabolism may be prolonged in liver disease due to decreased production of **pseudocholinesterase** (plasma cholinesterase) by the liver.

Q: Adrenalin increases all of the following blood pressures significantly except?

Diastolic. **Explanation:** The effect of Adrenaline (Epinephrine) on blood pressure is determined by its non-selective action on **$\alpha_1, \beta_1,$ and $\beta_2$ receptors**. 1. **Systolic BP (SBP):** Adrenaline significantly increases SBP primarily through its **$\beta_1$ agonist** action, which increases myocardial contractility (inotropy) and heart rate (chronotropy). 2. **Pulse Pressure:** Since SBP increases significantly while DBP remains relatively stable (or decreases slightly), the difference between the two—the pulse pressure—increases significantly. 3. **Mean BP:** Mean BP is a weighted average of SBP and DBP. Because the rise in SBP is substantial, the Mean BP generally shows a net increase. 4. **Diastolic BP (DBP):** This is the correct answer because the effect on DBP is **variable and dose-dependent**. At standard therapeutic doses, Adrenaline stimulates both $\alpha_1$ (vasoconstriction) and $\beta_2$ (vasodilation) receptors. The potent $\beta_2$ effect in skeletal muscle beds often offsets the $\alpha_1$ effect, leading to a DBP that may slightly rise, stay the same, or even fall. Therefore, it does not increase "significantly" compared to the other parameters. **High-Yield NEET-PG Pearls:** * **Dale’s Vasomotor Reversal:** If an $\alpha$-blocker (e.g., Phentolamine) is given before Adrenaline, the $\alpha_1$ effect is abolished, leaving the $\beta_2$ effect unopposed. This causes a paradoxical **fall** in BP. * **Drug of Choice:** Adrenaline is the DOC for **Anaphylactic Shock** (1:1000 IM) because it provides bronchodilation ($\beta_2$), increases BP ($\alpha_1, \beta_1$), and inhibits mast cell degranulation. * **Pure $\alpha$ agonist (Phenylephrine):** Increases both SBP and DBP, often leading to reflex bradycardia.

Q: Timolol is contraindicated in which of the following conditions?

COPD. **Explanation:** **Timolol** is a potent, **non-selective beta-adrenergic antagonist** (blocks both $\beta_1$ and $\beta_2$ receptors). **1. Why COPD is the Correct Answer:** The contraindication in **COPD** (and Bronchial Asthma) stems from the blockade of **$\beta_2$ receptors** located in the bronchial smooth muscles. Under normal physiological conditions, these receptors mediate bronchodilation. Blocking them leads to **bronchoconstriction**, which can precipitate a life-threatening bronchospasm in patients with reactive airway diseases. Even when administered topically as eye drops, systemic absorption through the nasolacrimal duct can occur, leading to systemic side effects. **2. Analysis of Incorrect Options:** * **A. Hypertension:** Timolol is actually used to treat hypertension (though less commonly now than newer agents) as it reduces cardiac output and renin release. * **B. Glaucoma:** This is the primary clinical indication for Timolol. It reduces aqueous humor production by the ciliary body, making it a first-line treatment for Open-Angle Glaucoma. * **C. Aphakia:** This refers to the absence of a lens. While epinephrine is contraindicated in aphakia (due to the risk of cystoid macular edema), Timolol is safe and commonly used to manage post-operative intraocular pressure. **Clinical Pearls for NEET-PG:** * **Betaxolol** is a $\beta_1$ selective (cardioselective) blocker and is the preferred beta-blocker for glaucoma patients who also have co-existing respiratory issues, as it has a lower risk of causing bronchospasm. * **Other Contraindications for Timolol:** Bradycardia, second or third-degree AV block, and overt heart failure (due to negative inotropic and chronotropic effects). * **Tip:** To minimize systemic absorption of Timolol eye drops, patients are advised to perform **nasolacrimal occlusion** (pressing the inner corner of the eye) for 1-2 minutes after instillation.

Q: Organophosphorus compounds exert their effects by which of the following mechanisms?

Inhibiting acetylcholinesterase. **Mechanism of Action: Organophosphorus (OP) Compounds** **Explanation of the Correct Answer (B):** Organophosphorus compounds act as potent **irreversible inhibitors of the enzyme Acetylcholinesterase (AChE)**. Under normal physiological conditions, AChE is responsible for breaking down the neurotransmitter Acetylcholine (ACh) into choline and acetic acid at the synaptic cleft. OP compounds bind to the active site (serine hydroxyl group) of the enzyme, forming a stable phosphoryl-enzyme complex. This inhibition leads to the **accumulation of Acetylcholine** at muscarinic and nicotinic receptors, resulting in a "cholinergic crisis." **Why Other Options are Incorrect:** * **Option A:** Stimulating AChE would lead to a rapid depletion of acetylcholine, which is the opposite of the clinical presentation of OP poisoning (miosis, secretions, bradycardia). * **Option C:** OP compounds do not block receptors; they increase the concentration of the ligand (ACh) that acts on those receptors. Drugs like Atropine are the ones that block receptors (muscarinic). **High-Yield Clinical Pearls for NEET-PG:** * **Aging of Enzyme:** Initially, the OP-AChE bond can be broken by Oximes (Pralidoxime). However, after a period (minutes to hours), the bond becomes permanent through a process called "aging," after which Oximes are no longer effective. * **Clinical Features:** Remember the mnemonic **DUMBELS** (Diarrhea, Urination, Miosis, Bronchospasm/Bradycardia, Emesis, Lacrimation, Salivation). * **Management:** * **Atropine:** Specific antidote (physiological antagonist) that blocks muscarinic effects. Titrated until "Atropinization" (clear lungs, heart rate >80 bpm). * **Pralidoxime (2-PAM):** Cholinesterase regenerator; must be given before "aging" occurs. * **Post-mortem Finding:** Characteristic **kerosene-like or garlic-like odor** from the mouth and stomach contents.

Q: Neostigmine is used in which of the following conditions, except?

Glaucoma. **Explanation:** **Neostigmine** is a synthetic quaternary ammonium compound that acts as a reversible anticholinesterase. It increases the concentration of acetylcholine at both nicotinic and muscarinic receptors. **Why Glaucoma is the correct answer (Except):** While Neostigmine is a potent cholinesterase inhibitor, it is **not used in Glaucoma** because it is a quaternary ammonium compound. This means it is highly polar and has **poor lipid solubility**, resulting in inadequate penetration across the cornea. For Glaucoma, tertiary amines like **Physostigmine** or direct-acting miotics like **Pilocarpine** are preferred as they penetrate ocular tissues more effectively. **Analysis of Incorrect Options:** * **Myasthenia Gravis:** Neostigmine is a drug of choice for symptomatic treatment. It inhibits AChE at the neuromuscular junction, increasing ACh levels to compete with antibodies for nicotinic receptors ($N_m$), thereby improving muscle strength. * **Cobra Bite:** Cobra venom contains post-synaptic neurotoxins that block $N_m$ receptors. Neostigmine (administered with Atropine to block muscarinic side effects) increases ACh levels to displace the toxin and reverse respiratory paralysis. * **Atony of Bladder:** Due to its muscarinic action ($M_3$), Neostigmine stimulates the detrusor muscle and relaxes the trigone/sphincter, making it useful for treating post-operative non-obstructive urinary retention. **Clinical Pearls for NEET-PG:** 1. **Reversal of Muscle Relaxants:** Neostigmine is the standard agent used to reverse the skeletal muscle paralysis induced by non-depolarizing neuromuscular blockers (e.g., d-Tubocurarine). 2. **Physostigmine vs. Neostigmine:** Remember that Physostigmine is a tertiary amine (crosses BBB; used for Atropine poisoning), while Neostigmine is a quaternary amine (does not cross BBB). 3. **Post-op Ileus:** Neostigmine is also used in Ogilvie’s syndrome (acute colonic pseudo-obstruction).

Q: Which of the following is a selective alpha antagonist?

Prazosin. ### Explanation **Correct Answer: B. Prazosin** **Mechanism and Concept:** Prazosin is a highly **selective $\alpha_1$-adrenergic antagonist**. It works by competitively blocking $\alpha_1$ receptors on vascular smooth muscle, leading to vasodilation of both arterioles and veins. This reduces peripheral vascular resistance and blood pressure without significant tachycardia, as it spares the presynaptic $\alpha_2$ receptors (which regulate norepinephrine feedback). **Analysis of Incorrect Options:** * **A. Propranolol:** This is a **non-selective $\beta$-blocker** ($\beta_1$ and $\beta_2$). It has no significant antagonist activity at $\alpha$ receptors. * **C. Phentolamine:** This is a **non-selective $\alpha$-antagonist** (blocks both $\alpha_1$ and $\alpha_2$). Because it blocks presynaptic $\alpha_2$ receptors, it causes a significant increase in norepinephrine release, leading to reflex tachycardia. * **D. Clonidine:** This is a **selective $\alpha_2$-agonist** (centrally acting). It reduces sympathetic outflow from the brainstem and is used as an antihypertensive, not an antagonist. **High-Yield Clinical Pearls for NEET-PG:** * **First-Dose Phenomenon:** Prazosin can cause marked orthostatic hypotension and syncope with the initial dose. Patients should be advised to take the first dose at bedtime. * **BPH Management:** Selective $\alpha_1$ blockers (especially **Tamsulosin**, which is $\alpha_{1A}$ selective) are first-line for Benign Prostatic Hyperplasia as they relax the prostatic urethra. * **Pheochromocytoma:** Non-selective $\alpha$-blockers like **Phenoxybenzamine** (irreversible) or Phentolamine (reversible) are used pre-operatively to manage catecholamine crises. * **Mnemonic:** The "-osin" suffix (Prazosin, Terazosin, Doxazosin) typically denotes selective $\alpha_1$ blockers.

Q: Why is atropine added to pyridostigmine in the treatment of myasthenia gravis?

To decrease muscarinic side effects. ### Explanation **1. Why Option B is Correct:** Pyridostigmine is an acetylcholinesterase inhibitor used to treat Myasthenia Gravis. By inhibiting the breakdown of acetylcholine (ACh), it increases ACh levels at the **nicotinic receptors** of the neuromuscular junction (NMJ) to improve muscle strength. However, this increase in ACh is non-selective and also occurs at **muscarinic receptors** throughout the body. This leads to unwanted parasympathetic overstimulation, causing side effects like abdominal cramps, diarrhea, excessive salivation, and bradycardia. Atropine, a muscarinic antagonist, is added to block these peripheral muscarinic effects without interfering with the desired nicotinic action at the NMJ. **2. Why Other Options are Incorrect:** * **Option A:** Pyridostigmine is a quaternary ammonium compound; it does not cross the blood-brain barrier significantly. Therefore, central excitation is generally not a concern requiring atropine. * **Option C:** Atropine does not alter the metabolism or pharmacokinetics of pyridostigmine; it only manages the side-effect profile. * **Option D:** Myasthenia Gravis is an autoimmune disorder. Pyridostigmine and atropine provide symptomatic relief but do not modify the underlying disease progression (which usually requires steroids or immunosuppressants). **3. Clinical Pearls for NEET-PG:** * **Drug of Choice:** Pyridostigmine is the preferred long-term oral treatment for Myasthenia Gravis due to its longer duration of action compared to Neostigmine. * **Edrophonium (Tensilon Test):** Used for diagnosis and to differentiate between a **Myasthenic crisis** (improvement with edrophonium) and a **Cholinergic crisis** (worsening with edrophonium). * **Antidote:** Atropine is the specific antidote for cholinergic crisis/organophosphate poisoning to reverse life-threatening muscarinic effects (DUMBELS).

Q: Which neuromuscular blocker is an example of one that causes hypotension?

Atracurium. **Explanation:** The correct answer is **Atracurium**. The primary mechanism behind the hypotension caused by certain neuromuscular blockers (NMBs) is **histamine release** and, to a lesser extent, autonomic ganglion blockade. **Why Atracurium is correct:** Atracurium belongs to the benzylisoquinolone class of non-depolarizing NMBs. These drugs are notorious for triggering the mast cell release of histamine. Histamine causes systemic vasodilation and increased capillary permeability, leading to a drop in blood pressure (hypotension) and often a compensatory tachycardia and flushing. **Analysis of Incorrect Options:** * **Pancuronium (Option C):** This drug typically causes **hypertension** and tachycardia rather than hypotension. It possesses "vagolytic" properties (blocks muscarinic receptors in the heart) and stimulates the sympathetic nervous system. * **Vecuronium (Option B) and Rocuronium (Option A):** These are amino-steroid compounds. They are designed to be "cardiovascularly stable" because they do not trigger significant histamine release and lack vagolytic effects at clinical doses. **High-Yield Clinical Pearls for NEET-PG:** * **Hofmann Elimination:** Atracurium and Cisatracurium undergo spontaneous non-enzymatic degradation in the plasma. This makes them the **drugs of choice in patients with liver or kidney failure**. * **Laudanosine Toxicity:** A metabolite of atracurium (laudanosine) can cross the blood-brain barrier and may cause **seizures** at high concentrations. * **Cisatracurium:** It is an isomer of atracurium that is more potent and, importantly, **does not cause histamine release**, making it more hemodynamically stable than atracurium. * **Mivacurium:** Another benzylisoquinolone that causes significant histamine release and hypotension, but it is short-acting.

Question 1

Lid retraction is a side effect of which anti-glaucoma drug?

Accepted Answer

Brimonidine

Answer

Latanoprost

Answer

Brinzolamide

Answer

Pilocarpine

Question 2

Which skeletal muscle relaxant is the drug of choice in patients with liver failure?

Accepted Answer

Atracurium

Answer

Gallamine

Answer

Thiopentone

Answer

Lignocaine

Question 3

Adrenalin increases all of the following blood pressures significantly except?

Accepted Answer

Diastolic

Answer

Systolic

Answer

Mean BP

Answer

Pulse pressure

Question 4

Timolol is contraindicated in which of the following conditions?

Accepted Answer

COPD

Answer

Hypertension

Answer

Glaucoma

Answer

Aphakia

Question 5

Organophosphorus compounds exert their effects by which of the following mechanisms?

Accepted Answer

Inhibiting acetylcholinesterase

Answer

Stimulating acetylcholinesterase

Answer

Blocking acetylcholinesterase receptors

Answer

None of the above

Question 6

Neostigmine is used in which of the following conditions, except?

Accepted Answer

Glaucoma

Answer

Myasthenia gravis

Answer

Cobra bite

Answer

Atony of bladder

Question 7

Which of the following is a selective alpha antagonist?

Accepted Answer

Prazosin

Answer

Propanolol

Answer

Phentolamine

Answer

Clonidine

Question 8

Why is atropine added to pyridostigmine in the treatment of myasthenia gravis?

Accepted Answer

To decrease muscarinic side effects

Answer

To prevent central excitation

Answer

To prolong the effect of neostigmine

Answer

To delay the progression of the disease

Question 9

Which neuromuscular blocker is an example of one that causes hypotension?

Accepted Answer

Atracurium

Answer

Rocuronium

Answer

Vecuronium

Answer

Pancuronium

Question 10

Anti-cholinesterases are ineffective against which of the following?

Accepted Answer

Carbamate poisoning

Answer

Belladonna poisoning

Answer

Postoperative ileus

Answer

Cobra bite

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?